• 한국토양비료학회지
• /
• 제4권1호
• /
• pp.13-19
• /
• 1971

수도생육초기(水稻生育初期)에 흡수조해물질(吸收阻害物質)의 생성집적(生成集積)이 우려(憂慮)되는 전형적(典型的)인 습답(濕畓)의 개량방법(改良方法)을 확립(確立)시키기 위(爲)해서 적지(適地)를 선정(選定) 석회질물질(石灰質物質), 무류산근비료(無硫酸根肥料), 붕소(硼素) 생고등(生藁等)을 첨가처리(添加處理) 한 포장시험(圃場試驗)을 실시(實施)하고 시기별식물체시료(時期別植物體試料)의 채취분석(採取分析)을 실시(實施)하여 그 결과(結果)들을 평가검토(評價檢討)한 결과(結果) 대략(大約) 다음과 같이 요약(要約)할수 있었다. (1) 습답(濕畓)에서는 소석회(消石灰), 규회석(珪灰石)과 같은 석회질물질(石灰質物質)의 첨가(添加) 붕(硼) 사등(砂等)과 같은 미생물(微生物)의 활동억제물질(活動抑制物質), 무류산근비료(無硫酸根肥料)와 같은 유해물질생성원(有害物質生成源)이 없는 물질(物質)의 시용(施用)으로 현저(顯著)한 정조수양증수(精租收量增收)를 기(期)할수있다. (2) 습답(濕畓)에 있어서 작물학적(作物學的)인 감수원인(減收原因)은 주당수수(株當穗數) 수당입수(穗當粒數), 1000입중등(粒重等)이 감소(減少)되는것이다. (3) 습답(濕畓)에서의 식물영양학적(植物營養學的)인 감수원인(減收原因)은 전생육기간(全生育期間)을 통(通)한 질소흡수조해(窒素吸收阻害)와 유수형성기(幼穗形成) 이후(以後)의 인발흡목조해(燐醱吸牧阻害), 수확기고중(收穫期藁中)의 고토(苦土), 석회(石灰) 규산함량(硅酸含量)의 감소(減少)때문이다. (4) 습답(濕畓)에서의 각종성분(各種成分)의 수도체중함량감소원인(水稻體中含量減少原因)은 다음과 같은 관찰사실(觀察事實)로부터 흡수조해물질(吸收阻害物質)의 생성집적(生成集積)으로 인(因)한 근계(根系)의 피해(被害)때문이라고 추정(推定)된다. (가) 흡수조해물질(吸收阻害物質)의 생성집적(生成集積)이 최고(最高)에 이르는 유수형성기(幼穗形成期)에 있어서 인산(燐酸)의 식물체당함량(植物體當含量)은 인산무처리구(燐酸無處理區)보다 인산시용구(燐酸施用區)에서 적었으며 석회질물질시용(石灰質物質施用)으로 중화(中和)된 구(區)에서는 훨씬 많았다. (나) 생고시용구(生藁施用區)에서 유수형성기(幼穗形成期) 식물체중가리함량(植物體中加里含量)은 필경 생고분해과정(生藁分解過程)에서 생성(生成)된 흡수조해물질(吸收阻害物質)때문에 매우 낮었으나 수확기(收穫期)에는 높았으며 필경 피해근(被害根)에 의(依)한 소극적(消極的) 비대사흡수(非代謝吸收) 때문이다. (다) 유기물(有機物)을 분해(分解)하는 미생물(微生物)의 작용(作用)을 조해(阻害)하는 것으로 알려진 붕소(硼素)의 효과(效果)가 현저(顯著)하였다. (라) 유화수소(硫化水素)와 같은 흡수조해물질생성원(吸收阻害物質生成源)이 없는 무류산근비료처리(無硫酸根肥料處理)의 효과(效果)가 현저(顯著)하였다. (마) 흡수조해물질(吸收阻害物質)의 생성집적량(生成集積量)이 최고(最高)에 이르며 근(根)의 활력(活力)이 최저(最低)에 이르는 유수형성기전후(幼穗形成期前後)에 결정(決定)되는 수량구성요소(收量構成要素)들이 모두 감소(減少)된다.

• 한국자원식물학회:학술대회논문집
• /
• 한국자원식물학회 2005년도 춘계 학술발표대회
• /
• pp.140-140
• /
• 2005

• Tuberculosis and Respiratory Diseases
• /
• 제75권6호
• /
• pp.236-237
• /
• 2013

Many attempts have been made to find genetic abnormalities inducing carcinogenesis after the development of epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor targeting EGFR in lung cancer. New target therapies have been already commercialized and studied along with the recent discovery of gene rearrangement involved in the carcinogenic process of non-small cell lung cancer. This study aims to investigate anplastic lymphoma kinase, c-ros oncogene 1, and receptor tyrosine kinase, in particular.

• 한국잠사학회:학술대회논문집
• /
• 한국잠사학회 2004년도 International Conference of Sericultural and Entomological Sciences
• /
• pp.85-86
• /
• 2004

• 한국응용약물학회:학술대회논문집
• /
• 한국응용약물학회 1998년도 Proceedings of UNESCO-internetwork Cooperative Regional Seminar and Workshop on Bioassay Guided Isolation of Bioactive Substances from Natural Products and Microbial Products
• /
• pp.167-168
• /
• 1998

Swainsonine is a toxic indolizidine alkaloid found in the plant, Swainsona species (Dorling, 1978; Colgate, 1979). It is a potent inhibitor of the glycoprotein processing pathway in the Golgi apparatus. Specifically, it inhibits mannosicase II resulting in abherrant high mannose glycans. Recent studies showed that swainsonine prevents metastasis of tumor cells and it inhibits solid growth tumor, at least partially (Goss et al., 1994; Baptista et al, 1994).

• Journal of Microbiology
• /
• 제44권2호
• /
• pp.243-247
• /
• 2006

Mycobacterium sp. strain JC1 was capable of growth on benzylamine as a sole source of carbon and energy. The primary deamination of benzylamine was mediated by an inducible amine oxidase, which can also oxidize tyramine, histamine, and dopamine. Inhibitor study identified this enzyme as a copper-containing amine oxidase sensitive to semicarbazide.

• 한국환경성돌연변이발암원학회:학술대회논문집
• /
• 한국환경성돌연변이발암원학회 2001년도 Korean Environmental Mutagen Society
• /
• pp.150-150
• /
• 2001

• Journal of Digestive Cancer Research
• /
• 제3권1호
• /
• pp.11-16
• /
• 2015

The discovery of HER2, a biomarker in advanced gastric cancer, and successful clinical trial using trastuzumab that targets this biomarker signaled a revolutionary turning point in treatment of metastatic gastric cancer. Many studies about targeted agents for gastric cancer have been attempted. Among them, ramicirumab, a monoclonal antibody that targets vascular endothelial growth factor receptor-2 (VEGFR-2), and apatinib, a tyrosine kinase inhibitor (TKI) that targets VEGFR2, have shown to improve the survival rates in advanced gastric cancer patients, for whom previous therapies had failed; hence, they are expected to be accepted as one of the standard therapies for advanced gastric cancer.

• Asian Pacific Journal of Cancer Prevention
• /
• 제17권8호
• /
• pp.3829-3833
• /
• 2016

Inhibition of cancer-associated fibroblasts (CAFs) may improve the efficacy of cancer therapy. Polysaccharide extracted from polygonatum can selectively inhibit the growth of prostate-CAFs (p<0.001) without inhibiting the growth of normal fibroblasts (NAFs). Polysaccharides from polygonatum stimulate autophagy of prostate-CAFs. 3-methyl-adenine(3-MA) is an autophagy inhibitor. 3-MA was added to prostate-CAFs with polysaccharide from polygonatum to determine whether autophagy plays an important role in the restrained effect. Finally, polysaccharide from polygonatum treatment significantly increased the activation of Beclin-1 and LC3, key autophagy proteins. Polysaccharide from polygonatum stimulates autophagy of prostate-CAFs and inhibits prostate-CAF growth, indicating that a novel anti-cancer strategy involves inhibiting the growth of prostate-CAFs.

• Biomolecules & Therapeutics
• /
• 제20권2호
• /
• pp.165-170
• /
• 2012

Cell migration plays a role in many physiological and pathological processes. Reactive oxygen species (ROS) produced in mammalian cells influence intracellular signaling processes which in turn regulate various biological activities. Here, we investigated whether melanoma cell migration could be controlled by ROS production under normoxia condition. Cell migration was measured by wound healing assay after scratching confluent monolayer of B16F10 mouse melanoma cells. Cell migration was enhanced over 12 h after scratching cells. In addition, we found that ROS production was increased by scratching cells. ERK phosphorylation was also increased by scratching cells but it was decreased by the treatment with ROS scavengers, N-acetylcysteine (NAC). Tumor cell migration was inhibited by the treatment with PD98059, ERK inhibitor, NAC or DPI, well-known ROS scavengers. Tumor cell growth as judged by succinate dehydrogenase activity was inhibited by NAC treatment. When mice were intraperitoneally administered with NAC, the intracellular ROS production was reduced in peripheral blood mononuclear cells. In addition, B16F10 tumor growth was significantly inhibited by in vivo treatment with NAC. Collectively, these findings suggest that tumor cell migration and growth could be controlled by ROS production and its downstream signaling pathways, in vitro and in vivo.